63(top 2%)
papers
2.9K(top 1%)
citations
29(top 1%)
h-index
55(top 1%)
g-index
68
all documents
3.1K
doc citations
914
citing journals

Top Articles

#TitleJournalYearCitations
1The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation studyBreast Cancer Research and Treatment2009260
2Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramAnnals of Oncology2018246
3Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studiesEuropean Journal of Cancer2011227
4Long-term toxic effects of adjuvant chemotherapy in breast cancerAnnals of Oncology2011221
5HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient dataLancet Oncology, The2011165
6Facts and Controversies in Systemic Treatment of Metastatic Breast CancerOncologist2004152
7Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?Annals of Oncology2002128
8A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast CancerClinical Cancer Research2020102
9Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancerAnnals of Oncology200397
10Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancerNature Reviews Clinical Oncology201097
11Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology201095
12Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast CancerCell Cycle200676
13Treatment of cancer during pregnancy with monoclonal antibodies: a real challengeExpert Review of Clinical Immunology201074
14Uncovering the genomic heterogeneity of multifocal breast cancerJournal of Pathology201572
15New therapies for ovarian cancer: Cytotoxics and molecularly targeted agentsCritical Reviews in Oncology/Hematology200869
16Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology200969
17Monoclonal Antibody-Based Targeted Therapy in Breast CancerDrugs200662
18Stemming Resistance to HER-2 Targeted TherapyJournal of Mammary Gland Biology and Neoplasia200957
19Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring and more …Breast201157
20Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialBreast Cancer Research and Treatment201155
21Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAsBreast Cancer Research and Treatment201145
22Motherhood after breast cancer: searching for la dolce vitaExpert Review of Anticancer Therapy201141
23Targeting the Ubiquitin—Proteasome Pathway in Breast CancerClinical Breast Cancer200440
24The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen responseCritical Reviews in Oncology/Hematology200739
25Quantitation of HER2 Expression or HER2:HER2 Dimers and Differential Survival in a Cohort of Metastatic Breast Cancer Patients Carefully Selected for Trastuzumab Treatment Primarily by FISHDiagnostic Molecular Pathology200938
26Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?Clinical Breast Cancer200337
27Targeting mTOR in cancer: renal cell is just a beginningTargeted Oncology201035
28Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) statusAnnals of Oncology201535
29Microarray technology and its effect on breast cancer (re)classification and prediction of outcomeBreast Cancer Research200334
30Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-α gene amplification and protein overexpression in locally advanced/metastatic breast cancerInternational Journal of Oncology200430
31Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancerInternational Journal of Oncology200429
32Micrometastatic disease in breast cancer: Clinical implicationsEuropean Journal of Cancer200827
33Development and Validation of Gene Expression Profile Signatures in Early-Stage Breast CancerCancer Investigation200923
34Frequent incidence of BARD1‐truncating mutations in germline DNA from triple‐negative breast cancer patientsClinical Genetics201623
35Use and abuse of taxanes in the management of metastatic breast cancerEuropean Journal of Cancer200322
36Inconsistent Criteria Used in American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology200821
37Topoisomerase IIα as a Marker Predicting the Efficacy of Anthracyclines in Breast Cancer: Are We at the End of the Beginning?Clinical Breast Cancer200319
38Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerBritish Journal of Cancer201217
39Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeBrain Communications202116
40New data on chemotherapy in the adjuvant settingBreast200315
41Breast cancer gene expression profiling: clinical trial and practice implicationsPharmacogenomics200514
42Simultaneous targeting of estrogen receptor and HER2 in breast cancerExpert Review of Anticancer Therapy201014
43Sowing the Soil for Cure? Results of the ABCSG-12 Trial Open a New Chapter in the Evolving Adjuvant Bisphosphonate Story in Early Breast CancerJournal of Clinical Oncology200912
44The best use of chemotherapy in the adjuvant settingBreast200311
45First-Line Treatment of Metastatic Breast CancerAmerican Journal of Cancer200611
46Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the LiteratureCase Reports in Oncological Medicine201311
47Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?ESMO Open201810
48Optimizing Anthracycline Therapy for Node Positive Breast CancerAmerican Journal of Cancer20027
49Novel therapeutics in breast cancer—Looking to the futureUpdate on Cancer Therapeutics20097
50ecancermedicalscienceEcancermedicalscience20116